Bladder cancer trials in Peru

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  Where

  Lima, San Isidro

  Age

  18 years and over

  People

  308 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06833073 · EU 2024-517335-46-00